Pauline Mohr - Koninklijke DSM Member of the Supervisory Board

KDSKF Stock  USD 43.01  0.09  0.21%   

Executive

Ms. Pauline van der Meer Mohr has served as Independent Member of the Supervisory Board of Royal DSM NV since April 28, 2011. She is Chairman of Remuneration Committee and Member of the Nominating Committee of the Company. She was President of the Executive Board of Erasmus University Rotterdam. in her professional career Ms. van der Meer Mohr also was appointed Independent NonExecutive Director of HSBC Holdings and Mylan, Chair Supervisory Board EY Netherlands, Monitoring Committee Dutch Corporationrationrate Governance Code and Board of Trustees Nederlands Danstheater, Member SelectionNomination Committee Supreme Court of the Netherlands, and Capital Markets Committee AFM. since 2011.
Age 58
Tenure 13 years
Phone31 45 578 8111
Webhttps://www.dsm.com
van der Meer Mohr also serves as Member of the Supervisory Board of ASML N.V., Chair of the Supervisory Board of the Rotterdam School of Management, Member of the Supervisory Board of Nederlandse School voor Openbaar Bestuur, Director of the Hollandsche Maatschappij van Wetenschappen, Member of the Economic Development Board of Rotterdam and Member of the Duisenberg School of Finance Board. She is Chairman of Corporationrationrationrate Social Responsibility Committee.

Koninklijke DSM Management Efficiency

The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.84 B in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Koninklijke DSM NV has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Koninklijke DSM until it has trouble settling it off, either with new capital or with free cash flow. So, Koninklijke DSM's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Koninklijke DSM NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Koninklijke to invest in growth at high rates of return. When we think about Koninklijke DSM's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Christopher MecrayDupont De Nemours
N/A
Evgeny AnAir Products And
N/A
Marvin MendozaPPG Industries
N/A
Jose DesalesDupont De Nemours
N/A
Steven LarrabeeDupont De Nemours
62
Karl SchmittSherwin Williams Co
N/A
Siddharth ManjeshwarAir Products And
N/A
William PellicciottiAir Products And
44
Chancey HagertyPPG Industries
50
Alisha BellezzaPPG Industries
48
Peg CurryPPG Industries
N/A
Jaime IrickPPG Industries
50
Joanne MullenEcolab Inc
N/A
Irene TasiPPG Industries
N/A
Randy KochPPG Industries
N/A
Kevin WallingPPG Industries
59
Malesia DunnPPG Industries
N/A
David BingenheimerEcolab Inc
N/A
Alexa DembekDupont De Nemours
N/A
Matthew PerinKroger Company
N/A
Simon MooreAir Products And
N/A
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. KONINKLIJKE DSM operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people. Koninklijke DSM NV [KDSKF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Koninklijke DSM NV Leadership Team

Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Routs, Chairman of the Supervisory Board
Eileen Kennedy, Member of the Supervisory Board
Ewald Kist, Deputy Chairman of the Supervisory Board
Frits Paasschen, Independent Member of the Supervisory Board
John Ramsay, Independent Member of the Supervisory Board
Stefan Doboczky, Member of the Managing Board
Paul Gilgen, Head Products
Lieke JongTops, Communications Mang
Stephan Tanda, Member of the Managing Board
Geraldine Matchett, CFO and Member of the Managing Board
Luca Rosetto, VP Products
Dimitri Vreeze, Member of the Managing Board
Dave Huizing, Vice President Investor Relations
Rob Atsma, Head Nederland
Pauline Mohr, Member of the Supervisory Board
Victoria Haynes, Member of the Supervisory Board
Jan Wolters, Head Chemicals
Bruno Mller, Head Products
Pradeep Pant, Member of the Supervisory Board
Manfred Eggersdorfer, VP Advocacy
Feike Sijbesma, Chairman of the Managing Board and CEO
Pierre Hochuli, Member of the Supervisory Board
Tom Swaan, Member of the Supervisory Board

Koninklijke Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Koninklijke DSM in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Koninklijke DSM's short interest history, or implied volatility extrapolated from Koninklijke DSM options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Koninklijke DSM NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Koninklijke Pink Sheet analysis

When running Koninklijke DSM's price analysis, check to measure Koninklijke DSM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Koninklijke DSM is operating at the current time. Most of Koninklijke DSM's value examination focuses on studying past and present price action to predict the probability of Koninklijke DSM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Koninklijke DSM's price. Additionally, you may evaluate how the addition of Koninklijke DSM to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Please note, there is a significant difference between Koninklijke DSM's value and its price as these two are different measures arrived at by different means. Investors typically determine if Koninklijke DSM is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Koninklijke DSM's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.